Abstract
Objective To determine the prevalence of microembolic signals(MES) by using transcranial Doppler(TCD) and to assess their association with neuropsychiatric systemic lupus erythematosus(NPSLE) and clinical presentations in patients with systemic lupus erythematosus(SLE). Methods Forty-four patients with SLE underwent TCD for 30 min were included for MES detection and their clinical information were recorded. In addition to the frequency of patients with MES, patients with MES were followed-up for six-month. Mann-Whitney U test and Fisher exact test were applied to investigate the clinical characteristics. Results There were 4 patients with history of NPSLE and the occurrence times were from 8 to 120 month before our study. There were 4 patients had the abnormal neuropsychiatric symptom during our study period. MES were detected in 5/44 patients(11%) with mean 17.6 per 30 min. MES were more prone to be detected in patients with higher systemic lupus erythematosus disease activity index(SLEDAI) score [16(12.5, 19)vs 8(5, 10), U=14.5,P=0.001], shorter course of disease [1(0.1, 48.5)vs 26(13, 55),U=38,P=0.028] and neuropsychiatric symptoms [3 vs 1, P=0.003]. Conclusion MES may be detected in SLE patients. MES is associated with higher disease activity, shorter course of disease and NPSLE. TCD microemboli detection may be a noninvasive method to evaluate NPSLE patients. Key words: Lupus erythematosus, systemic; Neuropsychiatric lupus; Transcranial Doppler; Microembolic signals
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call